Angio-tumoral laminin in murine tumors derived from human melanoma cell lines. Immunohistochemical and ultrastructural observations

Journal of Submicroscopic Cytology and Pathology

Volumn 30, Issue 2, 1998, Pages 231-237

  Lugassy, C ^a   Christensen, L ^b   Charpentier, M Le ^a   Faure, E ^c   Escande, J P ^a  

^a Institut Cochin   (France)

^b University of Copenhagen   (Denmark)

^c IGR   (France)

Author keywords

Angio tumoral complex; Endothelial cell; Laminin; Melanoma cell; Migration; Pericyte

Indexed keywords

LAMININ;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL CULTURE; DISEASE MODEL; ENZYME IMMUNOASSAY; HUMAN; MELANOMA; METABOLISM; MOUSE; PATHOLOGY; SECRETION; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOENZYME TECHNIQUES; LAMININ; MELANOMA; MICE; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED;

EID: 0032037346     PISSN: 11229497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. BECK K., HUNTER I. and ENGEL J., 1990. Structure and function of laminin: anatomy of a multidomain glycoprotein. Faseb J., 4, 148-160.
2. BERNSTEIN J.J. and KARP S.M., 1996. Migrating fetal astrocytes do not intravasate since they are excluded from blood vessels by vital basement membrane. Int. J. Dev. Neurosci., 14, 177-180.
3. BUSAM K.J., BERWICK M., BLESSING K., FANDREY K., KANG S., KARAOLI T., FINE J., COCHRAN A.J., WHITE W.L., RIVERS J., ELDER D.E., PO WEN D-R., HEYMAN B.H. and BARNHILL R., 1995. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. Am. J. Pathol., 147, 1049-1056.
4. CLARK E.A. and BRUGGE J.S., 1995. Integrins and signal transduction pathways: the road taken. Science, 268, 233-239.
5. DAMSKY C.H. and WERB Z., 1992. Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Cell Biol., 4, 772-781.
6. D'AMORE P.A. and SHIMA D.T., 1996. Tumor angiogenesis: a physiological process or genetically determined? Cancer Metastasis Rev., 15, 205-212.
7. ELLIS L.M. and FIDLER I.J., 1996. Angiogenesis and metastasis. Eur. J. Cancer, 32A, 2451-2460.
8. ESCANDE J.P. and ESCANDE C., 1997. Biologies. De l'infection et du cancer. Collection Les Empêcheurs de penser en rond. 1 vol. Institut Synthelabo ed.
9. FORM D.M., PRATT B.M. and MADRI J.A., 1986. Endothelial cell proliferation during angiogenesis. In vitro modulation by basement membrane components. Lab. Invest., 55, 521-530.
10. FOX S.B. and HARRIS A.L., 1997. Markers of tumor angiogenesis. Clinical applications in prognosis and anti-angiogenic therapy. Invest. New Drugs, 15, 15-28.
11. GIANNELLI G., FALK-MARZILLIER J., SCHIRALDI O., STETLER-STEVENSON W. and QUARANTA W., 1997. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science, 277, 225-228.
12. HANAHAN D., 1997. Signaling vascular morphogenesis and maintenance. Science, 277, 48-50.
13. HANBY A.M., 1997. The molecular pathology of neoplasia. Cancer Metastasis Rev., 16, 1-3.
14. HIRSCHI K.K. and D'AMORE P.A., 1996. Pericytes in the microvasculature. Cardiovasc. Res., 32, 687-698.
15. INOUE T., NABESHIMA K., SHIMAO Y., KATAOKA H. and KOONO M., 1996. Modulation of fibronectin synthesis by cancer cell-fibroblast interaction: cancer cells stimulate fibronectin production and affect alternative splicing of fibronectin pre-mRNA at EDA region in fibroblasts. Int. J. Oncol., 9, 721-730.
16. JENQ W., WU S.J. and KEFALIDES N.A., 1994. Expression of the α2-subunit of laminin correlates with increased cell adhesion and metastatic propensity. Differentiation, 58, 29-36.
17. JEON H., ONO M., KUMAGAI C., MIKI K., MORITA A. and KITAGAWA Y., 1996. Pericytes from microvessel fragment produce type IV collagen and multiple laminin isoforms. Biosci. Biotechnol. Biochem., 60, 856-861.
18. KLINOWSKA T.C.M., IRELAND G.W. and KIMBER S.J., 1994. A new in vitro model of murine mesoderm migration: the role of fibronectin and laminin. Differentiation, 57, 7-19.
19. KÖPF-MAIER P. and FLUG M., 1996. Behavior of the basement membrane during carcinoma cell invasion in chemically induced carcinomas of the skin. Acta Anat., 155, 1-13.
20. KOSMEHL H., BERNDT A. and KATENKAMP D., 1996. Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects. Virchows Arch., 429, 311-322.
21. LENTZ S.I., MINER J.H., SANES J.R. and SNIDER W.D., 1997. Distribution of the ten known laminin chains in the pathways and targets of developing sensory axons. J. Comp. Neurol., 378, 547-161.
22. LILEY H.G., 1992. The contributions of the extracellular matrix to vascular form and function. Sem. Perinatal., 16, 155-160.
23. LOTZ M.M., NUSRAT A., MADARA J.L., EZZELL R., UM W. and MERCURIO A.M., 1997. Intestinal epithelial restitution. Involvement of specific laminin isoforms and integrin laminin receptors in wound closure of a transformed model epithelium. Am. J. Pathol., 150, 747-760.
24. LUGASSY C. and ESCANDE J.P., 1987. Reconstitution in vitro de mélanomes malins. C.R. Acad. Sci. Paris, 305, 507-512.
25. LUGASSY C. and ESCANDE J.P., 1991. Immunolocation of TNF-Alpha/Cachectin in human melanoma cells: studies on co-cultivated malignant melanoma. J. Invest. Dermatol., 96, 238-242.
26. LUGASSY C. and ESCANDE J.P., 1997a. Laminin in normal and invasive units: studies in normal human skin and malignant melanoma. J. Invest. Dermatol., 108, 626.
27. LUGASSY C. and ESCANDE J.P., 1997b. Letters to the Editors. Virchows Arch., 431, 371.
28. LUGASSY C., EYDEN B.P., CHRISTENSEN L. and ESCANDE J.P., 1997a. Angio-tumoral complex in human malignant melanoma characterised by free laminin: ultrastructural and immunohistochemical observations. J. Submicrosc. Cytol. Pathol., 29, 19-28.
29. LUGASSY C., EYDEN B.P., CHRISTENSEN L. and ESCANDE J.P., 1997b. Is the angio-tumoral complex in human malignant melanoma a marker of non hematogenous migration? Melanoma Res., 7, S95.
30. LUGASSY C., CHRISTENSEN L., LE CHARPENTIER M., FAURE E. and ESCANDE J.P. 1998. Ultrastructural and immunohistochemical observations concerning laminin in B16 melanoma. J. Submicrosc. Cytol. Pathol., 30, 137-144.
31. MAHESPARAN R., TYSNES B.B., EDVARDSEN K., HAUGELAND H.K., CABRERA I.G., LUND-JOHANSEN M., ENGEBRAATEN O. and BJERKVIG R., 1997. Role of high molecular weight extracellular matrix proteins in glioma cell migration. Neuropathol. Appl. Neurobiol., 23, 102-112.
32. MALINDA K.M. and KLEINMAN H.K., 1996. The laminins. Int. J. Biochem. Cell Biol., 28, 957-959.
33. MIZUSHIMA H., MIYAGI Y., KIKKAWA Y., YAMANAKA N., YASUMITSU H., MISUGI K. and MIYAZAKI K., 1996. Differential expression of laminin 5/Ladsin subunits in human tissues and cancer cell lines and their induction by tumor promoter and growth factors. J. Biochem., 120, 1196-1202.
34. NURSE P., 1997. Reductionism. The ends of understanding. Nature, 387, 657.
35. O'REILLY M.S., BOEHM T., SHING Y., FUKAL N., VASLOS G., LANE W.S., FLYNN E., BIRKHEAD J.R., OLSEN B.R. and FOLKMAN J., 1997. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88, 277-285.
36. PERRIS R., BRANDENBERGER R. and CHIQUET M., 1996. Differential neural crest cell attachment and migration on avian laminin isoforms. Int. J. Dev. Neurosci., 14, 297-314.
37. PYKE C., ROMER J., KALLUNKI P., LUND L.R., RALFKIAER E., DANO K. and TRYGGVASON K., 1994. The γ2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am. J. Pathol., 145, 782-790.
38. PYKE C., SALO S., RALFKIÆR E., ROMER J., DANO K. and TRYGGVASON K., 1995. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for uro-kinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res., 55, 4132-4139.
39. QUARANTA V. and PLOPPER G.E., 1997. Integrins and laminins in tissue remodeling. Kidney Int., 51, 1441-1446.
40. RAK J., FILMUS J. and KERBEL R.S., 1996. Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis. Eur. J. Cancer, 32A, 2438-2450.
41. RAY M.C. and GATELY L.E., 1996. Basement membrane zone. Clin. Dermatol., 14, 321-330.
42. RONNOV-JESSEN L., PETERSEN O.W. and BISSELL M.J., 1996. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev., 76, 69-125.
43. ROSKELLEY C.D. and BISSELL M.J., 1995. Dynamic reciprocity revisited: a continuous, bidirectional flow of information between cells and the extracellular matrix regulates mammary epithelial cell function. Biochem. Cell Biol., 73, 391-397.
44. STETLER-STEVENSON W.G., 1996. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am. J. Pathol., 148, 1345-1350.
45. STRACKE M.L., MURATA J., AZNAVOORIAN S. and LIOTTA A., 1994. The role of the extracellular matrix in tumor cell metastasis. In Vivo, 8, 49-58.
46. 4 integrin and newly deposited laminin-1 and laminin-5 from the adhesion mechanism of gastric carcinoma. Am. J. Pathol., 149, 781-793.
47. TIMPL R. and BROWN J.C., 1996. Supramolecular assembly of basement membranes. Bioessays, 18, 123-132.
48. TUSZYNSKI G.P., WANG T.N. and BERGER D., 1997. Adhesive proteins and the hematogenous spread of cancer. Acta Hæmatol., 97, 29-39.
49. WEAVER V.M., PETERSEN O.W., WANG F., LARABELL C.A., BRIAND P., DAMSKY C. and BISSELL M.J., 1997. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol., 137, 231-245.
50. YAO C.-C., ZIOBER B.L., SQUILLACE R.M. and KRAMER R.H., 1996. α7 integrin mediates cell adhesion and migration on specific laminin isoforms. J. Biol. Chem., 271, 25598-25603.
51. ZIOBER B.L., LIN C.S. and KRAMER R.H., 1996. Laminin-binding integrins in tumor progression and metastasis. Cancer Biol., 7, 119-128.